Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Frazier Healthcare Partners and Pivotal BioVenture Partners Co-Lead $64M Series B In Biopharmaceutical Startup
Venture Capital

Frazier Healthcare Partners and Pivotal BioVenture Partners Co-Lead $64M Series B In Biopharmaceutical Startup

by prnewswire.com posted 1year ago 454 views
SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced the closing of a $60 million Series B financing.